HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fonseca, V. A. Search for Related Content PubMed Articles by Fonseca, V. A. Social Bookmarking                What's this?

Diabetes Care: Moving (a Little) in the Winds of Change

From the Tulane University Health Sciences Center, New Orleans, Louisiana

Address correspondence and reprint requests to Vivian Fonseca, MD, FRCP, Tulane University Health Sciences Center, Division of Endocrinology, Department of Medicine, 1430 Tulane Avenue, SL 53, New Orleans, LA 70112. E-mail: vfonseca@tulane.edu

The first 20% of the full text of this article appears below.

Upon completion of my first year as Editor-in-Chief of Diabetes Care, and on behalf of our Editorial Board and staff, it is time to consider our success and evaluate the challenges ahead. Also, after 30 years, it is appropriate to thank our founding Editor Jay Skyler, who reflects on the history of the journal in a separate Editorial in this issue (1).

First, I am pleased with the very smooth transition of the journal, which was achieved with very little, if any, increase in turn-around time of manuscripts or publication delays. This was obviously due to the continuation of the tenure of many of the Associate Editors from the previous editorship and, most importantly, the retention of our outstanding team in the editorial office.

The journal’s continued success can be judged by the higher and progressive rise of its impact factor, its worldwide readership, and its increasing submission rate. The latter must reflect increased funding for clinical research in diabetes over the last few years. While we are delighted with this increase, it presents new challenges, such as a 75% rejection rate, resulting in some disgruntled authors. Inevitably, many well-written manuscripts on well-conducted studies do not meet our priorities at the time of submission. This has resulted in a greater portion of manuscripts being rejected without full peer review, although an Associate Editor or I will have always reviewed the manuscript, and the short decision time may be a benefit.

We continue to . . . [Full Text of this Article]

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Asleh, S. Blum, S. Kalet-Litman, J. Alshiek, R. Miller-Lotan, R. Asaf, W. Rock, M. Aviram, U. Milman, C. Shapira, et al. Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype Diabetes, October 1, 2008; 57(10): 2794 - 2800. [Abstract] [Full Text] [PDF]

				K. J. Miller and A. V. Azzara An Old Dog Learns a New Trick: Regulation of Peripheral Glucose Homeostasis by the Serotonin (5-HT)2C Receptor Mol. Interv., April 1, 2008; 8(2): 73 - 77. [Abstract] [Full Text] [PDF]